Tag.bio's COVID Lifeline
We are applying the Tag.bio platform to deliver accessibility and investigation of COVID clinical trials. Potential target users include: patients, doctors, advocates, pharma, regulators, financials.
We are applying the Tag.bio platform to deliver accessibility and investigation of COVID clinical trials. Potential target users include: patients, doctors, advocates, pharma, regulators, financials.
Log in or sign up for Devpost to join the conversation.